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Abstract
Sperm DNA fragmentation has been associated with reduced fertilization rates, embryo
quality, pregnancy rates and increased miscarriage rates. Various methods exist to test
sperm DNA fragmentation such as the sperm chromatin structure assay (SCSA), the sperm
chromatin dispersion (SCD) test, the terminal deoxynucleotidyl transferase mediated deox-
yuridine triphosphate nick end labelling (TUNEL) assay and the single cell gel electrophore-
sis (Comet) assay. We performed a systematic review and meta-analysis to assess the
value of measuring sperm DNA fragmentation in predicting chance of ongoing pregnancy
with IVF or ICSI. Out of 658 unique studies, 30 had extractable data and were thus included
in the meta-analysis. Overall, the sperm DNA fragmentation tests had a reasonable to good
sensitivity. A wide variety of other factors may also affect the IVF/ICSI outcome, reflected by
limited to very low specificity. The constructed hierarchical summary receiver operating
characteristic (HSROC) curve indicated a fair discriminatory capacity of the TUNEL assay
(area under the curve (AUC) of 0.71; 95% CI 0.66 to 0.74) and Comet assay (AUC of 0.73;
95% CI 0.19 to 0.97). The SCSA and the SCD test had poor predictive capacity. Importantly,
for the TUNEL assay, SCD test and Comet assay, meta-regression showed no differences
in predictive value between IVF and ICSI. For the SCSA meta-regression indicated the pre-
dictive values for IVF and ICSI were different. The present review suggests that current
sperm DNA fragmentation tests have limited capacity to predict the chance of pregnancy in
the context of MAR. Furthermore, sperm DNA fragmentation tests have little or no difference
in predictive value between IVF and ICSI. At this moment, there is insufficient evidence to
recommend the routine use of sperm DNA fragmentation tests in couples undergoing MAR
both for the prediction of pregnancy and for the choice of treatment. Given the significant
limitations of the evidence and the methodological weakness and design of the included
studies, we do urge for further research on the predictive value of sperm DNA fragmentation
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for the chance of pregnancy after MAR, also in comparison with other predictors of preg-
nancy after MAR.
Introduction
Traditionally, the diagnosis of male subfertility is based upon the analysis of semen volume
and sperm concentration, motility and morphology. Although there is a direct relationship
between semen quality and pregnancy rates both in natural conception and after medically
assisted reproduction (MAR), there is no definite predictive threshold for success for conven-
tional semen parameters [1–4]. Conventional semen analysis does not assess all aspects of the
function of testis and sperm quality. New tests for predicting the chance of pregnancy would
be clinically useful. There have been attempts to propose sperm DNA fragmentation as such a
new test for male reproductive capability [5].
The integrity of our genome is continuously challenged by endogenous metabolic by-prod-
ucts and exogenous factors. Depending on variables like cell type, cell cycle stage and the type of
DNA damage, a cell has several ways to repair damaged DNA and inaccurate repair can have
different consequences [6,7]. While our somatic bodies inevitably die of old age or disease, the
germ line has to maintain sufficient DNA integrity to pass on our genome to forthcoming gen-
erations. DNA double-strand breaks (DSBs) are endogenously induced during spermatogenesis;
first during meiosis, to facilitate the formation of meiotic crossovers, and second during sper-
miogenesis, when the chromatin of the haploid round spermatids is compacted by the replace-
ment of histones by protamines [8,9]. Furthermore, the sperm may accumulate DNA damage
and fragmentation during maturation and storage in the epididymis [10–12]. Other causes of
sperm DNA fragmentation can be defective apoptosis, excessive reactive oxygen species (ROS)
production and decreased seminal antioxidants [13–23]. Also toxic effects of drugs, cigarette
smoking, pollution, and factors as xenobiotics, high testicular temperature (fever, varicocele)
and advanced age have been associated with increased sperm DNA damage [24–28].
Recent studies have highlighted the significance of sperm DNA integrity as an important
factor that affects functional competence of the sperm. Therefore the detection of sperm DNA
fragmentation could be clinically useful as part of fertility workup [29]. For this purpose, sev-
eral techniques that measure DNA fragmentation are available and have been evaluated in sep-
arate studies. In this systematic review we will assess the sperm chromatin structure assay
(SCSA), the sperm chromatin dispersion (SCD) test, the terminal deoxynucleotidyl transferase
mediated deoxyuridine triphosphate nick end labelling (TUNEL) and the single cell gel elec-
trophoresis (Comet) assay.
The SCSA bases its results on (1) the DNA fragmentation index (DFI), which is the percent-
age in the sample that have measurable increased red fluorescence due to acridine orange attach-
ing to a single strand portion of DNA at sites of DNA strand breaks and then collapsing into a
crystal that produces a metachromatic shift to red fluorescence under exposure to blue light and
(2) the percentage of high DNA stainability (HDS), which is due to excess histones and proteins
other than protamines that prevent full condensation of the sperm chromatin [30–32].
The SCD test, also known as Halo Sperm assay, estimates the level of DNA fragmentation
indirectly by quantification of the amount of nuclear dispersion/halo after sperm lysis and acid
denaturation to remove excess nuclear proteins [33,34].
The principle of TUNEL involves labelling of the 30-ends of single- and double-strand
breaks with biotinylated dUTPs. The incorporated labelled nucleotides can be quantified by
flow cytometry or (fluorescence) microscopy to determine the number of (apoptotic) sperm
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cells containing fragmented DNA [31]. However, double strand DNA can have breaks with no
exposed 3’OH end and thus not being labelled by the TUNEL assay.
The Comet assay quantifies the shape of the single cell nuclei after gel electrophoresis. Small
fragmented DNA has a faster rate of migration towards the anode in an electrophoretic field
(tail region) as compared to larger non-fragmented DNA (head region), leading to a typical
comet shape [30,31].
Using these tests, the percentage of sperm with fragmented DNA was shown to be comparable
in idiopathic subfertile men with normal sperm parameters and in subfertile men with abnormal
sperm parameters, and significantly higher in both these groups in comparison to fertile controls
[35–37]. However, we do not know whether MAR helps to overcome the negative effects of DNA
damage on the chance of pregnancy. We therefore performed a systematic review and meta-anal-
ysis to assess the value of measuring sperm DNA fragmentation in predicting the ongoing preg-
nancy chance after in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).
Materials and Methods
Search and selection strategy
The electronic databases Pubmed, Embase, Cochrane and CINAHL were searched from incep-
tion (September 1967) to January 2016 for articles which described sperm DNA fragmentation
tests and outcome after MAR. The Medical Subject Headings terms and/or text words that were
used in our search can be found in the appendix. We also manually reviewed the bibliographies
of retrieved original papers and review articles. We used the preferred reporting items for sys-
tematic review and meta-analysis checklist (PRISMA) while conducting this study (S1 Fig).
Titles and abstracts of all identified studies were screened and the full paper of the prese-
lected articles was read by two researchers (S.M. and M.C.). Both researchers extracted the
data from the article independently by using standardized data extraction forms. If 2x2 tables
could be constructed the study was selected for final inclusion. In the 2x2 tables, the numbers
of pregnant and non-pregnant women for different sperm DNA fragmentation cut-off values
were recorded. Any disagreement between the two researchers was resolved through discus-
sion or by consultation with a third researcher (I.S.).
Eligibility criteria
All studies investigating the effect of sperm DNA fragmentation detected by the SCSA, the
SCD test, the TUNEL assay or the Comet assay on the outcome of IVF and/or ICSI were con-
sidered eligible for inclusion. The search was restricted to studies in humans. Studies were
excluded if they had no original data available for retrieval and duplicate publications were
also excluded. Studies that included cycles with donor oocytes and experiments that asses
sperm DNA fragmentation in specific male factor pathologies e.g. azoospermia and co-inter-
vention experiments e.g. antioxidant treatment were excluded from analysis.
The primary study outcome was ongoing pregnancy (defined as the presence of a living
intrauterine fetus on transvaginal ultrasonography (TVU) at the 12th week of gestation).
Other study outcomes were clinical pregnancy (defined as the presence of a gestational sac on
TVU or other definitive clinical signs) and live birth (defined as a live-born baby 24 weeks
of gestation). All outcomes were reported per cycle.
Quality assessment
Each selected study was scored for their relevance and methodological quality by using the
QUADAS 2 (Quality Assessment of Diagnostic Accuracy Studies) checklist [38]. Furthermore
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the following characteristics of the studies were taken into consideration: data collection
method (prospective of retrospective), study design (cohort or randomized controlled trial
(RCT)) and study population.
Statistical analysis
Hierarchical summary receiver operating characteristic. In order to evaluate the overall
accuracy, including the whole range of possible thresholds, we used hierarchical summary
receiver operating characteristic (HSROC) plots to display the results of individual studies in a
ROC space, each study being plotted as a single sensitivity-specificity point. Reported estimates
for sensitivity and specificity from different studies may be based on different positivity thresh-
olds (explicitly due to cut-off values used, or implicitly related to the assessment method or
device used). If there are multiple thresholds reported in one study, we chose the threshold
that was most comparable to the others. Based on the binomial distributions of the true posi-
tives and true negatives we calculated a summary point, with a 95% confidence interval (CI)
and predictive interval by using STATA version 14 (Stata-Corp, College Station, Texas, USA).
As recommended for meta-analysis of diagnostic accuracy studies [39], we used hierarchical
models to obtain summary estimates of sperm DNA fragmentation test in terms of ability to
discriminate between men with lower and higher probabilities of pregnancy. Separate HSROC
curves for IVF and ICSI were performed when sufficient studies were available.
An area under the curve (AUC) of 1 implies perfect discrimination, whereas an AUC of 0.5
means that the test does not discriminate at all [40]. For this review, a test is considered to
have a poor predictive accuracy if the AUC lies between 0.50 and 0.70. An AUC between 0.70
and 0.80 represents a fair predictive accuracy, and an AUC above 0.80 represents a good pre-
dictive accuracy.
In cases where insufficient data was available to perform HSROC analyses for clinical preg-
nancy, (ongoing) pregnancy or live birth independently, different pregnancy outcomes were
combined when minimal differences in sensitivity and specificity were found. When minimal
differences in sensitivity and specificity were found, studies with different timing of the sperm
DNA fragmentation test (pre- and post-wash) were combined.
Pooled sensitivity and specificity. According to the bivariate method [41], sensitivity and
specificity with 95% CI were calculated and displayed in a forest plot. Sensitivity and specificity
of original studies were pooled with STATA, using a random effect model. This model was
chosen for explicating the heterogeneity between the included studies and to estimate the
between-study variance. The amount of heterogeneity was quantified by using the I2 statistic,
which represents the percentage of total variability across the studies that is due to heterogene-
ity instead of chance. Moderate heterogeneity is defined as a value < 50% [42].
Meta-regression. Meta-regression analysis was performed with type of fertility treatment as
covariable to determine if differences in fertility treatment affected the estimated effect of sperm
DNA fragmentation. The meta-regression analyses were performed using STATA subroutine
MIDAS. If the p-value was< 0.05, results were considered to indicate statistical significance.
Results
Systematic search, selection and data extraction
The electronic search resulted in 859 hits. Following the removal of duplicates and the addition
of studies by hand-search and screening of abstracts, 111 studies were identified to be poten-
tially eligible for inclusion (Fig 1).
After reading the manuscripts and assessing the inclusion criteria and methodological qual-
ity, 67 studies were found that evaluated the association between sperm DNA fragmentation
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Fig 1. Flowdiagram of search and selection strategy in a systematic review and meta-analysis of sperm DNA fragmentation tests and
pregnancy rates after MAR. Legend: not applicable.
doi:10.1371/journal.pone.0165125.g001
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and pregnancy after IVF or ICSI and 30 studies were eligible for final inclusion into the diag-
nostic meta-analyses. We excluded 81 studies for the reasons shown in Table 1.
Descriptive review
We found 21 studies reported on the SCSA [103,110–112,114,117,118,123–136], 18 studies on
the SCD test [97,98,101,102,106–109,113,115,116,120,122,137–141], 18 studies reported on the
TUNEL assay [92–95,96,99,100,104,119,134,142–149] and seven studies reported on the alka-
line Comet assay [95,105,121,134,150–152].
Studies selected for diagnostic meta-analysis
Characteristics of included studies are listed in Table 2. Most studies were of a prospective
cohort design and used pregnancy rate as outcome measure. Fig 2 and Table 3 show the scores
on overall risk of bias and concerns regarding applicability in this meta-analysis according to
QUADAS-2. For about half of the studies the threshold for sperm DNA fragmentation was not
pre-specified and hence was judged to be at ‘high risk’ of bias for QUADAS-2 domain ‘index
test’. Moreover, different cut-off values for DNA fragmentation were used to assess sperm
DNA as fragmented. Studies were at high risk of applicability concerns in domain “index test”
when the sperm DNA fragmentation threshold is not comparable to the thresholds of other
studies. For QUADAS-2 domain ‘flow and timing’ eight studies judged to be at ‘high risk’
because of an inappropriate interval between the sperm DNA fragmentation test and the fertil-
ity treatment. Overall the reference standard was judged to be at ‘low risk’.
Table 1. List of studies excluded from the meta-analysis.
Treatment with IUI method Alkhayal et al., 2013; Duran et al., 2002; Muriel et al., 2006; Yang
et al., 2011 [43–46]
Inappropriate inclusion criteria Dar et al., 2013; Gosalvez et al., 2013; Greco et al., 2005; Morris
et al., 2002; Nunez Calonge et al., 2012; Wang et al., 2012 [47–52]
Overlapping data Bungum et al., 2004; Bungum et al., 2008; Henkel et al., 2003; Jiang
et al., 2011; Larson et al., 2000; Simon et al., 2013 [53–58]
Outcome fertilization rate or
biochemical pregnancy
Cebesoy et al., 2006; Claassens et al., 1992; Daris et al., 2010; Host
et al., 2000; Lopes et al., 1998; Marchetti et al., 2002; Pregl Breznik
et al., 2013; Sadeghi et al., 2009; Sun et al., 1997 [36,59–66]
Use of assays not included in the
systematic review
Abu-Hassan et al., 2006; Angelopoulos et al, 1998; Chi et al., 2011;
Duran et al., 1998; Edwards et al., 2015; Filatov et al., 1999;
Hammadeh et al., 1996; 1998; 2001; 2001; Hoshi et al., 1996; Jiang
et al., 2011; Karydis et al., 2005; Katayose et al., 2003; Larazos et al.,
2011; Sakkas et al., 1996; Tavares et al., 2013; Tomlinson et al.,
2001; Virant-Klun et al., 2002; Zhang et al., 2008; Zini et al., 2005
[67–87]
Data not extractable because of
language
Bufang et al., 2011; Fang et al., 2011; Xi et al., 2016; Yang et al.,
2013 [88–91]
Insufficient data to construct 2x2
table
Avendano et al., 2010; Bakos et al., 2008; Benchaib et al., 2003;
Caglar et al., 2007; Garolla et al., 2015; Gu et al., 2009; 2011;
Hammadeh et al., 2006; 2008; Irez et al., 2014; Jin et al., 2015;
Kennedy et al., 2011; Khalili et al., 2014; Lewis et al., 2004; Li &
Jiang, 2011; Lopez et al., 2013; Meseguer et al., 2011; Nasr Esfahani
et al., 2008; Nicopoullos et al., 2008; Nijs et al., 2009; 2011; Rama
Raju et al., 2012; Saleh et al., 2003; Sanchez-Martin et al., 2013;
Sharbatoghli et al., 2012; Smit et al., 2010; 2010; Tarozzi et al., 2009;
Tavalaee et al., 2009; Tomsu et al., 2002; Velez de la calle et al.,
2008 [92–122]
doi:10.1371/journal.pone.0165125.t001
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Table 2. Descriptive data of all studies for the meta-analysis regarding SCSA, SCD test, TUNEL assay and Comet assay as tools for measure
sperm DNA fragmentation.
A. Characteristics of studies included in meta-analysis on SCSA
Study Pro-/ retrospective cohort Infertility Semen Treatment Cut-off DFI (%) No. cycles Outcome
Boe-Hanson 2006 Prospective Mixed Unclear IVF <27 139 CP
ICSI <27 47 CP
Bungum 2007 Prospective Mixed Pre-wash IVF <30 388 CP*, LB
ICSI <30 223 CP*, LB
Check 2005 Prospective Previously failed ART Unclear ICSI <30 106 CP, OP*
Gandini 2004 Prospective Mixed Pre-wash IVF <27** 12 P*, LB
ICSI <27** 22 P*, LB
Guerin 2005 Unclear Unclear Unclear IVF/ICSI <30 100 P
Larson-Cook 2003 Retrospective Not specified Pre-wash IVF/ICSI <27 89 CP, P*
Lin 2008 Pro- and retrospective Not specified Unclear IVF <9, <27* 137 CP
ICSI <9, <27* 86 CP
Micinski 2009 Prospective Not specified Unclear ICSI <15 60 P
Niu 2011 Prospective Mixed Post-wash IVF <27 256 CP, OP*
Oleszczuk 2016 Retrospective Mixed Pre-wash IVF <10, <20* 1117 P*, LB
ICSI <10, <20* 516 P*, LB
Payne 2005 Prospective Not specified Pre-wash IVF/ICSI <27 98 P
Simon 2014 Prospective Not specified Pre-wash IVF/ICSI <27 96 P
Speyer 2010 Pro- and retrospective Mixed Pre-wash IVF <19, <30* 192 P
ICSI <19, <30* 155 P
Virro 2004 Pro- and retrospective Not specified Pre-wash IVF/ICSI <30 249 OP
B. Characteristics of studies included in meta-analysis on SCD test
Study Pro-/retro-spective cohort Infertility Semen Treatment Cut-off DFI (%) No. cycles Outcome
Anifandis 2015 Prospective Not specified Pre-wash IVF/ICSI <35 156 CP*, OP
Ni 2014 Prospective Not specified Unclear IVF <30 855 CP*, LB
ICSI <30 227 CP*, LB
Muriel 2006 Prospective Not specified Post-wash IVF/ICSI <32.8 85 P
Wang 2014 Prospective Male infertility Pre- and post-wash ICSI <30 45 CP
Yilmaz 2010 Prospective Male infertility Pre-wash ICSI <30 60 P
C. Characteristics of studies included in meta-analysis on TUNEL assay
Study Pro-/retro-spective cohort Infertility Semen Treatment Cut-off DFI (%) No. cycles Outcome
Benchaib 2007 Prospective Not specified Post-wash IVF <15 88 CP, OP*
ICSI <15 234 CP, OP*
Borini 2006 Prospective Mixed Post-wash IVF <10 82 CP
ICSI <10 50 CP
Esbert 2011 Prospective Mixed Pre-wash IVF <36 77 CP
Frydman 2008 Prospective Mixed Pre-wash IVF <35 117 CP, OP*, LB
Henkel 2004 Prospective Not specified Pre-wash IVF <36.5 167 P
Huang 2005 Retrospective Not specified Post-wash IVF <4, <10, <15* 217 P
ICSI <4, <10, <15* 86 P
Ozmen 2007 Prospective Not specified Post-wash ICSI <4, <10* 42 CP
Seli 2004 Prospective Not specified Post-wash IVF/ICSI <20 49 CP
Simon 2014 Prospective Not specified Post-wash IVF/ICSI <10 224 P
D. Characteristics of studies included in meta-analysis on Comet assay
Study Pro-/retro-spective cohort Infertility Semen Treatment Cut-off DFI (%) No. cycles Outcome
Simon 2010 Prospective Not specified Pre- and post*-wash IVF <44, <56* 224 CP*, LB
ICSI <44, <56* 127 CP*, LB
Simon 2011 Prospective Male infertility Pre- and post*-wash IVF <42, <52* 70 P
Simon 2011 Prospective Mixed Pre- and post*-wash IVF <42, <52* 73 P
Simon 2014 Prospective Not specified Unclear IVF/ICSI <82 229 P
* used for meta-analysis
** threshold determined by authors of this review. CP: clinical pregnancy; DFI: DNA fragmentation index; LB: live birth; OP: ongoing pregnancy; P:
pregnancy; SCD: sperm chromatin dispersion; SCSA: sperm chromatin structure assay.
doi:10.1371/journal.pone.0165125.t002
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Fig 2. Overall risk of bias in meta-analysis. This figure illustrates the overall risk of bias in the meta-
analysis. The horizontal axis represents the number of studies included. The color of the bars represent the
risk of bias. Yellow: high risk, blue: low risk and grey: unclear risk.
doi:10.1371/journal.pone.0165125.g002
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SCSA
The predictive accuracy for pregnancy with MAR of the SCSA was poor. The HSROC curve
analysis indicated a sensitivity of 0.84 (95% CI 0.77 to 0.88) and specificity of 0.21 (95% CI
0.16 to 0.26) resulting in an AUC of 0.49 (95% CI 0.45 to 0.54) (Figs 3 and 4). Meta-regression
indicated a difference in predictive value between IVF and ICSI (p-value: 0.00) (Table 4). For
the seven studies on IVF separately the HSROC was 0.53 (95% CI 0.48 to 0.57). For the eight
studies on ICSI the HSROC was 0.45 (95% CI 0.40 to 0.49). For IVF the sensitivity of the DNA
fragmentation index was higher, however the specificity was lower. The low specificity points
to a low proportion of true negatives, indicating low sperm DNA fragmentation does not guar-
antee more pregnancies. There was significant heterogeneity across studies in sensitivity and
specificity (I2 statistic > 50%) (Fig 4, Table 4).
Table 3. Study characteristics according to QUADAS II recommendations to report the risk of bias for patient selection and the concerns for appli-
cability of data collected in manuscripts eligible for the meta-analysis.
Risk of bias Applicability concerns
Patient selection Index test Reference standard Flow and timing Patient selection Index test Reference standard
Anifandis 2015 low high low low low low low
Benchaib 2007 unclear high low high low low low
Boe-Hanson 2006 high high low high low low low
Borini 2006 low low low low low low low
Bungum 2007 low low low low low low low
Check 2005 high low low high high low low
Esbert 2011 low low low unclear low high low
Frydman 2008 low low low low low high low
Gandini 2004 low low low unclear low low low
Guerin 2005 unclear unclear low unclear unclear low low
Henkel 2004 unclear high low high low high low
Huang 2005 unclear unclear low low low low low
Larson-Cook 2003 low high low unclear low low low
Lin 2008 high high low unclear low low low
Micinski 2009 low low low unclear low high low
Muriel 2006 low high low low low high low
Ni 2014 high low low unclear low low low
Niu 2011 high high low low low low low
Oleszczuk 2016 low low low low low low low
Ozmen 2007 unclear high low low low low low
Payne 2005 low low low unclear low low low
Seli 2004 low high low low low low low
Simon 2010 low high low unclear low low low
Simon 2011 low high low high low low low
Simon 2011 low high low high low low low
Simon 2014 low high low high low high/low* low
Speyer 2010 low unclear low high low low low
Virro 2004 low low low low low low low
Wang 2014 low low low low low low low
Yilmaz 2010 low low low low low low low
* high risk for Comet, low risk for SCSA and TUNEL.
doi:10.1371/journal.pone.0165125.t003
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Fig 3. HSROC curve. Hierarchical summary receiver operating characteristic (HSROC) plot of sperm DNA fragmentation for prediction of (clinical)
pregnancy. Each circle on the plot represents the pair of sensitivity and specificity from a study and the size of the circle is scaled according to the
sample size of the study. The solid red block represents the summary sensitivity and specificity, and this summary point is surrounded by a 95%
confidence region (yellow dashed line) and 95% prediction region (green dotted line). Sperm DNA fragmentation in the prediction of (clinical)
pregnancy for all studies and all cut-off values of the DNA fragmentation index reported: (A) SCSA, (B) SCD test, (C) TUNEL assay and (D) alkaline
Comet assay. AUC: Area under the curve; HSROC: Hierarchical summary receiver operating characteristics.
doi:10.1371/journal.pone.0165125.g003
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SCD test
The predictive accuracy for pregnancy with MAR of the SCD test was poor. The HSROC
curve analysis indicated a sensitivity of 0.59 (95% CI 0.43 to 0.73) and specificity of 0.39 (95%
Fig 4. Forest plot. Forest plot of sperm DNA fragmentation according to the DNA fragmentation index for predicting pregnancy. The plot shows study-
specific estimates of sensitivity and specificity (with 95% confidence intervals). The studies are ordered according to the type of treatment: (A) SCSA, (B)
SCD test, (C) TUNEL assay and (D) alkaline Comet assay. CI: confidence interval.
doi:10.1371/journal.pone.0165125.g004
Table 4. Meta-regression analysis with type of fertility treatment as independent variable to determine whether this independent variable could be
of influence on the sensitivity and specificity of the sperm DNA fragmentation test.
Sperm DNA fragmentation test Sensitivity (95% CI) p-value* Specificity (95% CI) p-value** p-value*** I2
SCSA 0.69 (0.60–0.77) 0.00 0.33 (0.27–0.40) 0.00 0.00 91
SCD - - - - - -
TUNEL 0.79 (0.64–0.89) 0.52 0.33 (0.13–0.62) 0.60 0.59 0
Comet 0.63 (0.46–0.78) 0.08 0.60 (0.42–0.76) 0.99 0.12 52
* meta-regression sensitivity
** meta-regression specificity
*** meta-regression joint model; het-erogeneity was quantified by using the I2 statistic
doi:10.1371/journal.pone.0165125.t004
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CI 0.25 to 0.55) resulting in an AUC of 0.49 (95% CI 0.44 to 0.53) (Figs 3 and 4). There was sig-
nificant heterogeneity across studies in sensitivity and specificity (I2 statistic > 50%) (Fig 4).
TUNEL assay
The predictive accuracy for pregnancy with MAR of the TUNEL assay was fair. The HSROC
curve analysis indicated a sensitivity of 0.84 (95% CI 0.75 to 0.90) and specificity of 0.24 (95%
CI 0.11 to 0.44) resulting in an AUC of 0.71 (95% CI 0.66 to 0.74) (Figs 3 and 4). For the six
studies on IVF the AUC was comparable (0.72; 95% CI 0.68 to 0.76). Meta-regression indi-
cated no difference in predictive value between IVF and ICSI (p-value: 0.59) (Table 4). There
was no significant heterogeneity across studies in sensitivity and specificity (I2 statistic = 0%)
(Fig 4).
Comet assay
The predictive accuracy for pregnancy with MAR of the alkaline Comet assay was fair. The
HSROC curve analysis indicated a sensitivity of 0.79 (95% CI 0.61 to 0.90) and specificity of
0.60 (95% CI 0.48 to 0.71) resulting in an AUC of 0.73 (95% CI 0.19 to 0.97) (Figs 3 and 4).
Meta-regression indicated no significant difference in predictive value between IVF and ICSI
(p-value: 0.12) (Table 4). There was significant het-erogeneity across studies in sensitivity and
specificity (I2 statistic > 50%) (Fig 4).
Discussion
This current review and meta-analysis summarizes the available knowledge concerning the
value of sperm DNA fragmentation tests in the prediction of pregnancy after IVF or ICSI.
From the HSROC curves (Fig 3) it becomes clear that the SCSA and the SCD test have a poor
predictive value, whereas the predictive value of the TUNEL assay and Comet assay was fair.
All tests show higher sensitivity and lower specificity for their predictive power, indicating low
sperm DNA fragmentation does not guarantee more pregnancies. Overall, there was signifi-
cant statistical heterogeneity across studies (Fig 4).
We found six meta-analyses investigating the effect of sperm DNA fragmentation on live
birth or pregnancy after IVF and/or ICSI. In the meta-analysis of Evenson and Wixon there
was a non-significant trend towards the occurrence of pregnancy (odds ratio (OR) 1.6; 95% CI
0.92 to 2.94) when infertile couples were treated with IVF or ICSI and the DFI, determined by
the SCSA, was below 30% [153]. The meta-analysis of Li et al. found that the clinical pregnancy
rate decreased significantly for IVF patients with a high degree of sperm DNA fragmentation,
determined by the TUNEL assay (relative risk (RR) 0.68; 95% CI 0.54 to 0.85) [154]. In ICSI
clinical pregnancy rate was unaffected by DFI (RR 0.76; 95% CI 0.55 to 1.04). The meta-analy-
sis of Collins et al. found a significant association between sperm DNA fragmentation, deter-
mined by the TUNEL assay or SCSA, and pregnancy after IVF or ICSI (OR 1.44; 95% CI 1.03
to 2.03) [155]. The meta-analysis of Zhao et al. showed that the pregnancy rate decreased sig-
nificantly for IVF/ICSI patients with a high degree of sperm DNA fragmentation, determined
by several sperm DNA fragmentation tests (RR 0.81; 95% CI 0.70 to 0.95) [156]. The meta-
analysis of Zhang et al. showed that patients were more likely to get pregnant if DFI was less
than 27% (OR 1.44; 95% CI 1.19 to 1.74) [157]. The most recent meta-analysis of Osman et al.
found that the live birth rate after IVF and/or ICSI increased significantly in patients with low
sperm DNA fragmentation (RR 1.17; 95% CI 1.07 to 1.28) [158]. In all the above meta-analyses
the association between the sperm DNA fragmentation test and live birth or pregnancy was
determined and expressed as ORs and RRs. An association does however not imply that the
test actually has predictive value. Furthermore, we found several studies investigating the
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significance of sperm DNA fragmentation as a continuous variable in IVF and/or ICSI. These
studies were excluded from meta-analysis, because no cut-off values were used so a 2x2 table
could not be constructed from the data. Some of these studies found an association between
sperm DNA fragmentation and pregnancy [83,92,93,97,104,107], while others did not find an
association between sperm DNA fragmentation and conception [47,116]. In conclusion, we
think that the best way to judge the value of DNA fragmentation tests is by their predictive
capacity for the outcome of interest, ongoing pregnancy. Therefore the outcomes of our review
are not comparable with the outcomes of other reviewers that chose to just report on the asso-
ciation between sperm DNA fragmentation and pregnancy. The results of the individual stud-
ies that were not included in our and other reviews are conflicting and lack the statistic power
of a review.
Many studies investigated the predictive accuracy of sperm DNA fragmentation tests on
the outcome of MAR. It is of clinical importance to assess whether these tests can be used as a
prognostic tool, to distinguish couples who should be advised to undergo MAR or not. It has
been suggested that DNA fragmentation is a useful marker in the prediction of spontaneous
pregnancy in couples with unexplained subfertility. The chance of spontaneous conception
declines at sperm DNA fragmentation index values above 20% and approaches zero for values
over 30–40%. Low sperm DNA fragmentation however does not guarantee normal male fertil-
ity [159,160]. To our knowledge no study exists in which the spontaneous pregnancy chance is
compared with the chance after MAR for different DNA fragmentation values.
As mentioned before, the methods of assessment of sperm DNA integrity are different for
the different assays. The TUNEL assay and Comet assay are direct methods to assess DNA
strand breaks, whereas the SCSA and SCD test are indirect methods, which use the higher sus-
ceptibility of damaged DNA to denature and/or fragment in an acid solution. Possibly, the fair
predictive accuracy of the TUNEL assay and Comet assay, in comparison to the poor accuracy
found for other methods in our meta-analysis, is due to its direct method of assessment, which
may better reflect genome integrity of the sperm cells.
Besides integrity of sperm DNA, there are other factors that affect the probability to con-
ceive after MAR, primarily the quality and age of the oocyte [161]. Male germ cells are suscep-
tible to the accumulation of DNA lesions in fertilizing sperm because their DNA repair
capacity declines during the latter part of spermatogenesis [162]. In contrast, the oocyte is
capable of repairing DNA damage throughout oogenesis and provides gene products that are
responsible for repairing DNA damage in both parental genomes after fertilization [163,164].
However, the competency for DNA repair depends on the quality of the oocyte which declines
with age [108,161].
This review has brought forward some limitations in the available literature on DNA frag-
mentation tests that need to be addressed. First the study heterogeneity was high. Some studies
only included couples suffering with male subfertility, other studies only included couples
after previously failed MAR and others included all couples undergoing MAR. Second, the
timing of performing the sperm DNA fragmentation test was not uniform. Some studies per-
formed their test a few months before start of the MAR, others performed their test during
MAR; before or after semen preparation. In addition, different cut-off values were used to
assess sperm DNA as being fragmented and some studies did not even have a pre-specified
threshold. However, for this reason, a bivariate model was used for the HSROC curve analysis
in the present review, which allows for variations in the assessment of sperm DNA fragmenta-
tion and the choice of cut-off values. Another limitation is the reproducibility of sperm DNA
fragmentation assessment. Intra-assay variability appears to be different depending on which
sperm DNA fragmentation test is being used; previous studies reported this to be either small
but significantly different with the TUNEL assay [165] or small and not significantly different
Testing Sperm DNA Fragmentation in MAR
PLOS ONE | DOI:10.1371/journal.pone.0165125 November 10, 2016 13 / 23
using a alkaline Comet assay [166] and no difference using the SCSA test [32]. On the other
hand, inter-observer variability was found to be very similar [21,165,167]. Mainly the TUNEL
assay has many protocols, which makes comparison between laboratories hard and explains its
many clinical thresholds [168]. To take care of these problems, there is need for studies that
have been done with exacting protocols in the clinic and in the measuring laboratory on many
patients at one center for each kind of sperm DNA fragmentation test. Unfortunately, only few
studies/clinics meet these criteria [58,132,134,150–152].
It must also be mentioned that there was no correction for confounders possible. Insuffi-
cient data were available for potential confounders such as female age, male age, semen param-
eters and number of oocytes. Further research, for instance an IPD meta-analysis, must reveal
the possible interrelation of other factors with pregnancy chance.
Conclusions
Our systematic review and meta-analysis suggests that current sperm DNA fragmentation
tests have limited capacity to discriminate between couples who have a low chance to conceive
and couples who have a high chance to conceive after MAR. In addition, sperm DNA fragmen-
tation tests have little or no difference in predictive value between IVF and ICSI. At this
moment there is insufficient evidence to recommend the routine use of sperm DNA fragmen-
tation tests in couples undergoing MAR both for the prediction of pregnancy and for the
choice of treatment. Given the significant limitations of the evidence and the methodological
weakness and design of the included studies, we do urge for further research on the predictive
value of sperm DNA fragmentation for the chance of a spontaneous pregnancy or a pregnancy
after MAR.
Appendix
("dna damage"[MeSH Terms] OR ("dna"[All Fields] AND "damage"[All Fields]) OR "dna
damage"[All Fields]) OR ("dna"[All Fields] AND "fragmentation"[All Fields] OR "dna frag-
mentation"[All Fields]) AND ("humans"[MeSH Terms] OR "humans"[All Fields] OR "huma-
n"[All Fields]) AND ("comet assay"[MeSH Terms] OR ("comet"[All Fields] AND "assay"[All
Fields]) OR "comet assay"[All Fields] OR "comet"[All Fields]) OR ("Clin Mol Allergy"[Journal]
OR "cma"[All Fields]) OR SCSA[All Fields] OR ("chromatin"[MeSH Terms] OR "chromati-
n"[All Fields]) OR (" acridine orange" [All Fields]) OR ("in situ nick-end labeling"[MeSH
Terms] OR ("situ"[All Fields] AND "nick-end"[All Fields] AND "labeling"[All Fields]) OR "in
situ nick-end labeling"[All Fields] OR "tunel"[All Fields]) OR ("in situ nick end labelling"[All
Fields] OR "in situ nick-end labeling"[MeSH Terms] OR ("situ"[All Fields] AND "nick-
end"[All Fields] AND "labeling"[All Fields]) OR "in situ nick-end labeling"[All Fields] OR
("situ"[All Fields] AND "nick"[All Fields] AND "end"[All Fields] AND "labeling"[All Fields])
OR "in situ nick end labeling"[All Fields]) AND ("spermatozoa"[MeSH Terms] OR "spermato-
zoa"[All Fields] OR "sperm"[All Fields]) AND ("pregnancy"[MeSH Terms] OR "pregnan-
cy"[All Fields]).
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